ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Allyl bromide → (+/-)-4-(alpha-(trans-4-allyl-2,5-dimethyl-1-piperazinyl)-5-(tert-butyldimethylsilyloxy)-2-fluorobenzyl)-N,N-diethylbenzamide

HRID 2258330
印刷

反応式

HRID 2258330 の反応式
[CH3:1][C@H:2]1[CH2:7][NH:6][C@H:5]([CH3:8])[CH2:4][N:3]1[CH:9]([C:25]1[CH:37]=[CH:36][C:28]([C:29]([N:31]([CH2:34][CH3:35])[CH2:32][CH3:33])=[O:30])=[CH:27][CH:26]=1)[C:10]1[CH:15]=[C:14]([O:16][Si:17]([C:20]([CH3:23])([CH3:22])[CH3:21])([CH3:19])[CH3:18])[CH:13]=[CH:12][C:11]=1[F:24].[CH2:38](Br)[CH:39]=[CH2:40].C(=O)([O-])[O-].[Na+].[Na+]>>[OH-:16].[NH4+:3].[CH2:40]([N:6]1[C@H:5]([CH3:8])[CH2:4][N:3]([CH:9]([C:25]2[CH:37]=[CH:36][C:28]([C:29]([N:31]([CH2:34][CH3:35])[CH2:32][CH3:33])=[O:30])=[CH:27][CH:26]=2)[C:10]2[CH:15]=[C:14]([O:16][Si:17]([C:20]([CH3:23])([CH3:22])[CH3:21])([CH3:19])[CH3:18])[CH:13]=[CH:12][C:11]=2[F:24])[C@@H:2]([CH3:1])[CH2:7]1)[CH:39]=[CH2:38]
参加物実験手順後処理出典と根拠反応ノート

参加物

5

反応物 3

HCID 7841Allyl bromideHCID 10340Sodium CarbonateHCID 69941891(+/-)-4-(alpha-(trans-2,5-dimethyl-1-piperazinyl)-5-(tert-butyldimethylsilyloxy)-2-fluorobenzyl)-N,N-diethylbenzamide

生成物 2

HCID 14923Ammonium HydroxideHCID 69942360(+/-)-4-(alpha-(trans-4-allyl-2,5-dimethyl-1-piperazinyl)-5-(tert-butyldimethylsilyloxy)-2-fluorobenzyl)-N,N-diethylbenzamide
収率 78%

実験手順

The benzhydrylpiperazine from above (0.44 g, 0.83 mmol) was treated with allyl bromide (0.074 mL, 0.85 mmol) and anhydrous sodium carbonate (0.44 g, 4.2 mmol) as in Example 1. The product was purified by preparative thin layer chromatography (silica gel with dichioromethane:methanol:ammonium hydroxide/90:10:1)to give 0.37 g (78%) of (±)-4-(α-(trans-4-allyl-2,5-dimethyl-1-piperazinyl)-5-(tert -butyldimethylsilyloxy)-2-fluorobenzyl)-N,N-diethylbenzamide as a yellow oil. Reaction with tetraethylammonium fluoride hydrate in acetonitrile as in Example 1, followed by chromatography on silica gel with dichloromethane:methanol/4:1 gave 0.24 g (77%) of (±)-4-(α-(trans-4-allyl -2,5-dimethyl-1 -piperazinyl)-2-fluoro-5-hydroxybenzyl)-N,N-diethylbenzamide as a light amber resin. NMR (CDCl3): δ1.0-1.3 (m, 12H); 2.0-2.3 (m, 2H); 2.5-3.05 (m, 5H); 3.2-3.6 (br m, 5H); 5.1-5.3 (m, 2H); 5.25 and 5.55 (s, 1H); 5.7-6.0 (m, 1H); 6.5-7.2 (m, 3H); 7.25 (d, J=8 Hz, 2H); 7.4 (d, J=8 Hz, solution of the product in absolute ethanol was titrated to pH 4 with ethanolic hydrochloric acid, concentrated and treated with diethyl ether to precipitate 0.21 g (63%) of the monohydrochloride as an off-white powder. Calc. for C27H36FN3O2HCl 1.25 H2O: C, 63.27; H, 7.77; N, 8.20; Cl, 6.92. Found: C, 63.33; H, 7.78; N, 8.24; Cl, 7.00. Mass spectrum (Cl-CH4) m/z: 454 (M+1, 100%), 453 (M, 6%), 300 (17%), 153 (95%).

後処理

  1. customThe product was purified by preparative thin layer chromatography (silica gel with dichioromethane

出典と根拠

ORDレコード
ord-627930f4384a4a56ad93453d5d862eae
出典データセット
uspto-grants-1997_08
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US05658908

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート